Acella's $46.5M Drug Recall Settlement Gets Initial Signoff

By Peter McGuire · February 7, 2024, 6:41 PM EST

A Georgia federal judge on Wednesday gave preliminary approval of a nearly $46.5 million settlement from Acella Pharmaceuticals LLC to end a class action alleging the company sold worthless thyroid medication...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Faulkner v. Acella Pharmaceuticals, LLC

Case Number

2:22-cv-00092

Court

Georgia Northern

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

May 12, 2022